Article Details

Recalculate sample size based on serious adverse event: CDSCO Panel Tells Roche on ...

Retrieved on: 2024-03-25 14:07:49

Tags for this article:

Click the tags to see associated articles and topics

Recalculate sample size based on serious adverse event: CDSCO Panel Tells Roche on .... View article details on hiswai:

Excerpt

This came after the drug maker Roche presented the proposal to conduct a Phase IV clinical trial titled “A Phase IV, open-label, study evaluating the ...

Article found on: medicaldialogues.in

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up